Invesco Ltd. I Bio, Inc. Transaction History

Invesco Ltd.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.23 - $0.46 $13,669 - $27,338	-59,431 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$0.3 - $0.61 $434 - $882	-1,447 Reduced 2.38%	59,431 $25,000
Q4 2021 Feb 14, 2022	SELL	$0.55 - $1.04 $3,872 - $7,321	-7,040 Reduced 10.37%	60,878 $33,000
Q3 2021 Nov 15, 2021	BUY	$1.06 - $1.52 $12,212 - $17,511	11,521 Added 20.43%	67,918 $72,000
Q2 2021 Aug 17, 2021	SELL	$1.22 - $1.65 $36,532 - $49,409	-29,945 Reduced 34.68%	56,397 $85,000
Q1 2021 May 17, 2021	BUY	$1.18 - $2.62 $42,114 - $93,507	35,690 Added 70.46%	86,342 $133,000
Q4 2020 Feb 16, 2021	BUY	$1.05 - $2.24 $53,184 - $113,460	50,652 New	50,652 $53,000

Ticker IBIO
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,006,580
Market Cap $23.8M
Description
iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for t...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.